FiercePharma  Mar 14  Comment 
Takeda's inflammatory bowel disease treatment Entyvio, launched in 2014, has been delivering blockbuster-plus sales, and the Japanese drugmaker sees fertile territory for more growth in the Asia-Pacific region.
FiercePharma  Mar 1  Comment 
Takeda, which recently announced a $627 million deal to buy biotech TiGenix, is upping its bet on its stem cell therapy investment, with a new plant and 70 jobs at its manufacturing site in Ireland.
FiercePharma  Feb 23  Comment 
Takeda made R&D deals in neurological disorders and with academic institutes, China's crackdown on pollution has caused some supply issues for the pharma industry, Merck KGaA plans further manufacturing expansions in Asia, and more.
FierceBiotech  Feb 22  Comment 
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming up with two Seattle-based academic centers in a project focused on its key targets of cancer, gastrointestinal disease and neurological...
FierceBiotech  Feb 20  Comment 
Perennial biotech dealmaker Takeda is at it again, striking a new pact with Wave Life Sciences with a focus on a series of difficult-to-treat neurological disorders.
FiercePharma  Feb 4  Comment 
The art of interpreting patient preferences is getting a technology upgrade in a new Takeda initiative aimed at helping inflammatory bowel disease patients sort through available treatments.


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki